Deka   Report issue

For profit Phase 4
Founded: Manchester NH United States (1982)
Status: No NME R&D (1982)

Organization Overview

First Clinical Trial
2018
NCT03809416
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

DEKA S.r.l.